BM 72

Product Description

DRAP Product.Enl No. 00411000344 Composition: Baryta OxalsuccinicaD200+200C, ThymolD200+200C, NaphthoquinoneD200+200C, SulphonamideD200+200C Specific Indication: Prostate cancer often does not cause symptoms for many years but when the symptoms appear the disease may have spread beyond the general prostatic disorders and the symptoms include frequent urination especially at night, inability to urinate, difficult to hold urine, a weak or interrupted flow of urine, painful or burning urination and blood in the urine or semen. Painful ejaculation and frequent pain in the lower back, hips and upper thighs. General Indication: Prostate cancer is a malignant growth that consists of the cells from the prostate gland. The tumour usually grows slowly and remains confined to the gland for many years. During this time the tumour produces very little or no symptoms of abnormalities on physical examination. As the prostate cancer spreads, it involves the surrounding tissues. Symptoms and signs of the prostate (Malignant) are frequent urination especially at night, inability to urinate, difficult to hold urine, a weak or interrupted flow of urine, painful or burning urination, blood in the urine or semen. Painful ejaculation and frequent pain in the lower back, hips and upper thighs.